{"transactions":[{"id":817326,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T21:00:07.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":false,"shares":7529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares vested 1/48th on the first day of each month commencing February 1, 2022."}],"balance_after":161,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":7529},"source":{"system":"sec-edgar","filing":"0001873796-26-000006","document":"form4-04032026_050401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000006/form4-04032026_050401.xml","form_type":"4"}},{"id":817325,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T21:00:07.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":7529,"price":32,"value":240928.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001873796-26-000006","document":"form4-04032026_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000006/form4-04032026_050401.xml","form_type":"4"}},{"id":817324,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T21:00:07.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":7529,"price":3.18,"value":23942.22,"ownership":{"direct":true},"balance_after":7529,"source":{"system":"sec-edgar","filing":"0001873796-26-000006","document":"form4-04032026_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000006/form4-04032026_050401.xml","form_type":"4"}},{"id":823272,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T00:00:12.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":53735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.86,"expiration_date":"2031-07-23","underlying":"Common Stock","underlying_shares":53735},"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823271,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T00:00:12.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":61265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022."}],"balance_after":53735,"derivative":{"exercise_price":4.86,"expiration_date":"2031-07-23","underlying":"Common Stock","underlying_shares":61265},"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823270,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T00:00:12.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":53735,"price":31.0268,"value":1667225.098,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.39, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823269,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T00:00:12.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":53735,"price":4.86,"value":261152.1,"ownership":{"direct":true},"balance_after":53735,"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823268,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T00:00:12.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":61265,"price":30.168,"value":1848242.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":823267,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T00:00:12.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":61265,"price":4.86,"value":297747.9,"ownership":{"direct":true},"balance_after":61265,"source":{"system":"sec-edgar","filing":"0001873796-26-000004","document":"form4-04012026_080408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000004/form4-04012026_080408.xml","form_type":"4"}},{"id":944975,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:17.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":15500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001873796-26-000002","document":"form4-01072026_040113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000187379626000002/form4-01072026_040113.xml","form_type":"4"}},{"id":1311432,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service."}],"balance_after":5750,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-000871","document":"form4-01062025_070111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000871/form4-01062025_070111.xml","form_type":"4"}},{"id":1311431,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":2520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service."}],"balance_after":2520,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":2520},"source":{"system":"sec-edgar","filing":"0001415889-25-000871","document":"form4-01062025_070111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000871/form4-01062025_070111.xml","form_type":"4"}},{"id":1311430,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":11940,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001415889-25-000871","document":"form4-01062025_070111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000871/form4-01062025_070111.xml","form_type":"4"}},{"id":1688587,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:24.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":14280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service."}],"balance_after":14280,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":14280},"source":{"system":"sec-edgar","filing":"0001415889-24-000655","document":"form4-01042024_050116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000655/form4-01042024_050116.xml","form_type":"4"}},{"id":1688586,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:24.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":4460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service."}],"balance_after":4460,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":4460},"source":{"system":"sec-edgar","filing":"0001415889-24-000655","document":"form4-01042024_050116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000655/form4-01042024_050116.xml","form_type":"4"}},{"id":1688585,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:24.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":29250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":29250,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":29250},"source":{"system":"sec-edgar","filing":"0001415889-24-000655","document":"form4-01042024_050116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000655/form4-01042024_050116.xml","form_type":"4"}},{"id":2060841,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T22:00:25.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":3560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant."}],"balance_after":3560,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":3560},"source":{"system":"sec-edgar","filing":"0001415889-23-000634","document":"form4a-01062023_050101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000634/form4a-01062023_050101.xml","form_type":"4/A","original_submission_date":"2023-01-05"}},{"id":2063298,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T01:01:10.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. The award pertains to annual board service."}],"balance_after":19000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-23-000597","document":"form4-01052023_080158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000597/form4-01052023_080158.xml","form_type":"4"}},{"id":2063297,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T01:01:10.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":37770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2023, with the last month vesting on December 31, 2023, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":37770,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":37770},"source":{"system":"sec-edgar","filing":"0001415889-23-000597","document":"form4-01052023_080158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000597/form4-01052023_080158.xml","form_type":"4"}},{"id":2450299,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T02:00:57.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":7690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable.  The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":7690,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":7690},"source":{"system":"sec-edgar","filing":"0001415889-22-000283","document":"form4-01042022_090148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922000283/form4-01042022_090148.xml","form_type":"4"}},{"id":2624094,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":53940,"kind":"person","name":"Sabar Karimah Es","position":1,"cik":"0001873796","reported_name":"Sabar Karimah Es","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-27T22:31:54.000Z","date":"2021-07-23","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 25% on the first anniversary of the first day of the month following the Grant Date, with the remainder to vest at the rate of 1/36 per month thereafter. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted\nstock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":115000,"derivative":{"exercise_price":4.86,"expiration_date":"2031-07-23","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001104659-21-096408","document":"tm2123420-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465921096408/tm2123420-1_4seq1.xml","form_type":"4"}}]}